Published Paper Details:

This review explores recent breakthroughs in drug delivery systems, spotlighting nanoparticles, liposomes, and micelles as pivotal advancements. Nanotechnology emerges as a transformative force, facilitating targeted drug delivery and heightened bioavailability. The exploration extends to targeted delivery methodologies, embracing ligand-mediated targeting and stimulus-responsive systems to augment specificity. Nevertheless, challenges loom large, notably concerning biocompatibility, and safety, underscoring the imperative for tailored solutions. Negotiating the intricate interplay among drug attributes, carrier properties, and biological barriers demands nuanced strategies. Regulatory hurdles and approval procedures present additional obstacles, warranting adherence to stringent protocols. Prospects for the future pivot on mitigating these constraints, envisioning personalized medicine paradigms, and assimilating cutting-edge technologies such as artificial intelligence and 3D printing. By surmounting these impediments, drug delivery systems stand poised to redefine therapeutic landscapes, promising enhanced treatment modalities and patient outcomes.